Mahdia Bader ALDeen ALHaidar

Dr. Mahdia Bader ALDeen ALHaidar


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2025 in ASIDE Internal Medicine
Verified
Journal Article
Open access
PDF file
AYAli Al Yasari
Ali Al Yasari
MAMahdia Bader ALDeen ALHaidar
Mahdia Bader ALDeen ALHaidar
Mohamad Monif AsskerMohamad Monif Assker
Mohamad Monif Assker
SMART syndrome is a rare, delayed complication of brain radiation. The acronym SMART stands for stroke-like migraine attacks following radiation therapy. This case is one of the first to describe episodic vertigo, dysmetria, and impaired tandem gait following proton beam radiotherapy for a craniopharyngioma. An 18-year-old male presented with migraine headaches, upper and lower limb weakness, episodic vertigo, and dysmetria with impaired tandem gait. This occurred following proton-beam radiotherapy, which was completed at around 11 years of age for recurrent craniopharyngioma. Magnetic resonance imaging (MRI) of the brain demonstrated a T1 hyperintense signal in the cortex of the right parietal and temporal lobes consistent with SMART syndrome. In addition, a subcortical hyperintense signal was seen in the right parietal, temporal, and frontal lobes. Atypical presentations of SMART syndrome are out there, and it is essential to recognize them in patients presenting with neurological symptoms following radiation therapy so that diagnosis and treatment can be done.

9 April 2026 in JPGN Reports
Verified
Journal Article
Open access
PDF file
FAFadhel Al Ateeqi
Fadhel Al Ateeqi
ASAla K. Shaikhkhalil
Ala K. Shaikhkhalil
HTHaitham Talo
Haitham Talo
NJNaeem Jagirdar
Naeem Jagirdar
MAMahdia Bader ALDeen ALHaidar
Mahdia Bader ALDeen ALHaidar
Infantile hepatic hemangioma (IHH) can cause severe complications such as high‐output cardiac failure and growth faltering, requiring prompt diagnosis and intervention. In the absence of standardized treatment guidelines, propranolol has emerged as an effective and well‐tolerated therapy. We report a female infant with multifocal IHH who presented with high‐output cardiac failure, hepatomegaly, and growth faltering. She experienced rapid and sustained clinical as well as radiologic improvement with propranolol therapy. This case reinforces propranolol's role as a safe, effective first‐line therapy for symptomatic IHH and underscores the importance of early multidisciplinary care.